about
The ASGE guidelines for the appropriate use of colonoscopy in an open access system.Diagnostic yield of open access colonoscopy according to appropriateness.Increased prevalence of migraine in patients with uninvestigated dyspepsia referred for open-access upper gastrointestinal endoscopy.Effectiveness of a continuous quality improvement program on colonoscopy practice.Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology.Technical performance of colonoscopy: the key role of sedation/analgesia and other quality indicators.How thiopurines are used for the treatment of inflammatory bowel diseases: an Italian survey.Routine versus "on demand" sedation and analgesia for colonoscopy: a prospective randomized controlled trial.Inflammatory Bowel Disease Phenotype as Risk Factor for Cancer in a Prospective Multicentre Nested Case-Control IG-IBD Study.The use of thiopurines for the treatment of inflammatory bowel diseases in clinical practice.Persistence of "wild-type" and "e-minus" hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers.Management of warfarin-associated coagulopathy in patients with acute gastrointestinal bleeding: a cross-sectional physician survey of current practice.Ischemic colitis associated with rofecoxib.Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics.Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study.High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas.Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.Tumour Necrosis Factor Alpha in Segmental Colitis Associated with DiverticulaDetection of liver involvement in inflammatory bowel disease by abdominal ultrasound scanAntibodies to neutrophil cytoplasm in Italian patients with ulcerative colitis: sensitivity, specificity and recognition of putative antigensp-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosisQuality assurance and colonoscopyPrevalence and risk factors of Helicobacter pylori-negative peptic ulcer: a multicenter studyInflammatory bowel diseases are not associated with major hereditary conditions predisposing to thrombosisInfliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-upInfliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open studyHigh-dose senna compared with conventional PEG-ES lavage as bowel preparation for elective colonoscopy: a prospective, randomized, investigator-blinded trialSegmental colitis associated with diverticula: a 7-year follow-up studyCancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair studyPrognostic significance of endoscopic remission in patients with active ulcerative colitis treated with oral and topical mesalazine: a prospective, multicenter studyInfliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomyComplications and early mortality in percutaneous endoscopic gastrostomy placement in lombardy: A multicenter prospective cohort study
P50
Q30482094-9B4C6727-FEA1-41FA-AA4A-B7AD5C80770AQ30482210-C7FCC490-778A-4425-80B7-4CEDAC79BDA0Q30482905-BB66D184-2479-4DC1-B185-0A37229943ADQ30483378-F8E952B6-CF26-4E20-80F3-151970582D3AQ36127192-84DE99C4-C676-4F2F-8C09-6720FBCFB0A0Q38216510-7EAED91E-49AF-458A-8B68-6E3B4AA303B7Q38996677-18EEC718-A965-4DA3-B20E-86062723A39BQ40097447-428CE920-0B3F-407F-9BFE-3A6C3ED1EF3BQ40179623-588D2A70-DFDA-4514-A8D1-E292C28851DBQ40694876-F81A8001-D8B7-47DC-AFE8-250929D9C1BDQ40877160-AADCDA75-6894-4A93-956A-59A6ABA85343Q44408412-4B07057A-DF49-4F42-8B8A-ECDE1925BE9FQ44599784-428062F3-C572-473C-AB08-8AF5FAF8FAC3Q44946756-1038AEDC-E900-4838-A8B5-B8605EABD35DQ46447767-FE0AA469-324C-44AE-B471-5F7C9A4DE026Q46542650-A60BF238-4478-4137-8188-390F072F4BB9Q46842702-9647C2FD-70A7-4FF6-9988-CBF81006F863Q50910363-1EB4B079-605A-4400-83D4-33638CBEEE64Q51152919-E9525828-4D8D-4B0D-B628-9D791E18C0C0Q53115244-FA3F2BD0-1DE1-4F26-AF75-A814B3D9BDA2Q57821468-298B87B4-70D5-48F0-989A-27967C6FC340Q68133389-A24BC68E-95BB-4254-BE50-E72CEDAD6A08Q72252865-E65664B0-2692-4137-A22E-2F983AC9A0F0Q72692183-8E73005B-7B9B-42EA-A055-EE584F719741Q73113121-172CE5C4-5900-47E6-A16E-311D2F6CFC25Q74067475-70F28E4E-6E16-4394-B22E-118E25571F26Q74232061-0CF74BC7-1CEF-49DA-9E38-4B6549007C2FQ80793210-CBD6C33A-D0ED-470C-B746-BF633C55143AQ81734312-F76C4B1A-C7C4-4CD9-BA05-175C35E3454BQ82172789-0868828F-C691-4291-A246-9C1628E7BFCCQ83151272-0B183CA6-1368-40BB-A99A-A43375A577E2Q84656560-DB48A0D2-2D4A-4519-8A60-D9715A990479Q84735757-CAF9219E-490F-4691-9E82-60AC6B169A89Q87181170-710B4EC4-449E-412B-A18A-EAFF9506FB9CQ90211828-724FBE97-B033-497F-B94C-B8B44963AAAF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gianmichele Meucci
@ast
Gianmichele Meucci
@en
Gianmichele Meucci
@es
Gianmichele Meucci
@nl
type
label
Gianmichele Meucci
@ast
Gianmichele Meucci
@en
Gianmichele Meucci
@es
Gianmichele Meucci
@nl
prefLabel
Gianmichele Meucci
@ast
Gianmichele Meucci
@en
Gianmichele Meucci
@es
Gianmichele Meucci
@nl
P106
P1153
7003290123
P31
P496
0000-0001-9004-8195